Organs-on-a-Chip and faster Drug-to-market
The current drug development cycle is too costly, takes too long, and fails more often than it succeeds. Diseases go untreated and patients who need therapy...
February 15, 2014
The current drug development cycle is too costly, takes too long, and fails more often than it succeeds. Diseases go untreated and patients who need therapy...